HEREDITARY THYROID CANCER

Hereditary Thyroid Cancer — RET proto-oncogene variants cause medullary thyroid carcinoma with near-100% penetrance, and the specific RET codon determines whether prophylactic thyroidectomy should be performed in infancy, childhood, or adulthood.

Whole genome sequencing evaluates all hereditary thyroid cancer genes — RET (MEN2A/2B), DICER1 (differentiated thyroid cancer in children), APC (FAP-associated papillary thyroid cancer), PTEN (Cowden), and additional susceptibility variants.

RET
DICER1
PTEN
APC
PRKAR1A

About this condition

Thyroid Cancer — Hereditary

Hereditary thyroid cancer encompasses several genetic syndromes. The most clinically important is multiple endocrine neoplasia type 2 (MEN2), caused by activating variants in the RET proto-oncogene (chromosome 10q11.21). MEN2A (95% of MEN2) causes medullary thyroid carcinoma (MTC), pheochromocytoma, and hyperparathyroidism. MEN2B causes MTC, pheochromocytoma, mucosal neuromas, and marfanoid habitus. MTC penetrance in RET carriers approaches 100% — virtually all carriers will develop MTC if the thyroid is not removed prophylactically.

The specific RET codon determines the MTC aggressiveness and the recommended age for prophylactic thyroidectomy. 'Highest risk' (M918T — MEN2B): thyroidectomy in the first year of life, ideally by 6 months. 'High risk' (C634R, A883F): thyroidectomy by age 5. 'Moderate risk' (other codons): thyroidectomy can be considered based on calcitonin monitoring, often by mid-childhood to early teens. This codon-specific surgical timing is one of the most precise genotype-phenotype correlations in all of cancer genetics — and it requires molecular RET testing to implement.

Beyond RET/MEN2, other hereditary thyroid cancer syndromes include DICER1 syndrome (differentiated thyroid cancer in children, particularly multinodular goiter progressing to carcinoma), Cowden/PTEN hamartoma syndrome (follicular thyroid cancer — up to 35% lifetime risk), FAP/APC (papillary thyroid cancer, particularly the cribriform-morular variant in young women), and Carney complex (PRKAR1A — follicular thyroid adenomas). Non-medullary familial thyroid cancer (NMTC) with apparent autosomal dominant inheritance is described in ~5% of differentiated thyroid cancer, though specific genes are still being characterized.

RET M918T (MEN2B) requires thyroidectomy by age 6 months — MTC can metastasize in infancy. Every month of delayed RET testing in a child with mucosal neuromas and marfanoid features risks incurable metastatic MTC.

Gene locus: RET (10q11.21), DICER1 (14q32.13), PTEN (10q23.31), APC (5q22.2), PRKAR1A (17q24.2)

The specific RET codon determines whether thyroidectomy is performed at 6 months, age 5, or in adolescence. No other cancer gene has such precise codon–surgical timing correlation. Molecular RET testing is mandatory for MEN2 families.

Codon-specific prophylactic thyroidectomy timing — the most precise genotype-guided surgery in oncology

ATA guidelines stratify RET variants into risk categories with specific thyroidectomy timing recommendations. M918T carriers need thyroidectomy by 6 months. C634R carriers by age 5. Other codons allow individualized timing with calcitonin monitoring. This precision is only possible with molecular RET genotyping — clinical features alone cannot determine the codon. WGS identifies the exact RET variant, enabling optimal surgical timing that prevents MTC while minimizing the duration of thyroid hormone replacement.

DICER1 syndrome causes thyroid cancer in children — often presenting as multinodular goiter mistaken for benign disease

DICER1 pathogenic variants predispose to differentiated thyroid carcinoma in children and young adults, often arising within multinodular goiter. Without molecular DICER1 diagnosis, multinodular goiter in a child may be monitored conservatively — missing the malignant potential. DICER1 carriers also require surveillance for pleuropulmonary blastoma, ovarian sex cord-stromal tumors, and other DICER1-associated malignancies. WGS identifies DICER1 variants alongside RET and all other thyroid cancer genes.

Hereditary Thyroid Cancer — RET proto-oncogene variants cause medullary thyroid carcinoma with near-100% penetrance, and the specific RET codon determines whether prophylactic thyroidectomy should be performed in infancy, childhood, or adulthood.

Thyroid Cancer — Hereditary

The specific RET codon determines whether thyroidectomy is performed at 6 months, age 5, or in adolescence. No other cancer gene has such precise codon–surgical timing correlation. Molecular RET testing is mandatory for MEN2 families.

Codon-specific prophylactic thyroidectomy timing — the most precise genotype-guided surgery in oncology

DICER1 syndrome causes thyroid cancer in children — often presenting as multinodular goiter mistaken for benign disease

Others in Hereditary Cancer

One test. A lifetime of answers.